期刊文献+

急性冠脉综合征BNP与hs-CRP水平的相关性分析 被引量:2

Relevance analysis of acute coronary artery and syndrome BNP and hs-CRP level
下载PDF
导出
摘要 目的:探讨急性冠状动脉综合征(ACS)患者血清脑利钠肽(BNP)与高敏C-反应蛋白(hs-CRP)指标的相关性及其在ACS患者危险中的临床意义.方法:ACS患者52例,选择年龄、性别等与之相匹配稳定型心绞痛患者及其它疾病患者各40例做对照.酶联免疫吸附法测定血清BNP浓度,免疫比浊法测定hs-CRP浓度.结果:急性心肌梗死组和不稳定型心绞痛组患者的血清BNP浓度均明显高于稳定型心绞痛和其它疾病组患者,差异均具有统计学意义(P<0.01和P<0.05) 在ACS组中,BNP与hs-CRP具有相关性(P<0.05).结论:血清BNP浓度在ACS患者中明显升高,可作为辅助诊断指标之一.ACS患者血清BNP浓度升高程度与同期测定的血清hs-CRP呈显著正相关. Objective: Probe into acute coronary artery syndrome (ACS) patient serum brain favourable sodium peptide (BNP) and Gao Min C - response albumen relevance of index and in clinical meaning of being dangerous, patient of ACS. Methods: 52 ACS patients, Choose age, sex,etc, match it getting steady angina pectoris patient and other disease patient respectively 40 contrast of making. Enzyme unites the immune adsorption method and determines serum BNP density, The immunity determines hs-CRP density more than the turbid law. Result: Acute myocardium infarction group and getting unstable angina pectoris group density, BNP of serum, of patient higher than getting steady angina pectoris and other patient, group of disease, obviously, the difference has a statistics meaning (P〈0.01 and P〈0.05). Conclusion: Serum BNP density obviously rises among ACS patient, can be as assisting diagnosing one of the indexes. Density, BNP of serum, patient of ACS, rise intensity with serum that determine in the same term hs-CRP the prominent positive correlation.
作者 王志英
出处 《中医临床研究》 2010年第24期53-54,共2页 Clinical Journal Of Chinese Medicine
关键词 脑利钠肽 高敏C反应蛋白 急性冠脉综合征 Brain favourable sodium peptide Gao Min C reflects albumens Acute coronary artery and syndrome
  • 相关文献

参考文献2

二级参考文献36

  • 1Rabbani LE. Acute coronary syndromes-beyond myocyte necrosis. N Engl J Med,2001,345:1057-1059.
  • 2Clerico A, Iervasi G, Mariani G. Pathophysiologic relevance of measuring the plasma levels of cardiac natriuretic peptide hormones in humans. Horm Metab Res,1999,31:487-498.
  • 3Mair J, Friedl W, Thomas S, et al. Natriuretic peptides in assessment of left-ventricular dysfunction. Scand J Clin Lab Invest Suppl,1999,230:132-142.
  • 4Sagnella GA. Measurement and significance of circulating natriuretic peptides in cardiovascular disease. Clin Sci (Lond),1998,95:519-529.
  • 5Maewal P, de Lemos JA. Natriuretic peptide hormone measurement in acute coronary syndromes. Heart Fail Rev,2003,8:365-368.
  • 6Nagaya N, Nishikimi T, Goto Y, et al. Plasma brain natriuretic peptide is a biochemical marker for the prediction of progressive ventricular remodeling after acute myocardial infarction. Am Heart J,1998,135:21-28.
  • 7Berger R. Huelsman M, Strecker K, et al. B-type natriuretic peptide predicts sudden death in patients with chronic heart failure. Circulation,2002,105:2392-2397.
  • 8Omland T, de Lemos JA, Morrow DA, et al. Prognostic value of N-terminal pro-atrial and pro-brain natriuretic peptide in patients with acute coronary syndromes. Am J Cardiol,2002, 89:463-465.
  • 9McCullough PA, Sandberg KR. Sorting out the evidence on natriuretic peptides. Rev Cardiovasc,2003,4:S13-S19.
  • 10Kelly R, Struthers AD. Are natriuretic peptides clinically useful as markers of heart failure? Ann Clin Biochem,2001, 38:94-102.

共引文献67

同被引文献14

引证文献2

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部